Oklahoma City, Oklahoma 73105
For Immediate Release: April 26, 2011
Sen. Greg Treat
Senate advances measure to regulate
The state Senate on Tuesday approved legislation that would
require physicians to administer abortion inducing drugs in
accordance with U.S. Food and Drug Administration (FDA) guidelines.
Co-authored by Sen. Greg Treat, House Bill 1970 will protect
patients and promote life.
“I’m pleased to have the support of my colleagues in advancing
legislation that will defend life and help ensure the safety of
women,” said Treat, R-Oklahoma City. “It’s important these drugs are
subject to appropriate regulation under the law. Of the eight
reported deaths associated with abortion-inducing drugs in the
United States, seven were the result of doctors administering the
drug outside the approved FDA guidelines.”
Edmond Republican Randy Grau, principal author of the bill, said
HB 1970 will also require that patients are scheduled for a
follow-up appointment and are made aware of the proper usage and
effects of the drugs.
“The intent of this legislation is to ensure the safety of
pregnant women and better regulate the dangerous drugs that are used
in abortions,” said Grau, R-Edmond. “Each and every patient is
different and doctors should be required to perform an exam and
follow-up care before being prescribing an abortion-inducing drug.
This ensures the drugs are used appropriately and that any adverse
effects from the drug can be caught in a follow-up appointment. I
appreciate the bipartisan support this legislation has received.”
Daniel McConchie, Vice President of Government Affairs for
Americans United for Life praised Senate members for their passage
of the measure.
"With this overwhelming vote to regulate dangerous
abortion-inducing drugs, Oklahoma continues its leadership role in
defending human life and protecting women's health,” he said.
“Americans United for Life is proud to have partnered with Senator
Treat and Representative Grau on this important legislation."
HB 1970 will return to the House for consideration of Senate
For more information contact:
Sen. Treat: (405) 521-5632